Dasatinib |
|
Synonyms: N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS-354825; | |
Cat. No.: D25000 | CAS No.: 302962-49-8 |
MDL.: | Formula: C22H26ClN7O2S |
F.W.488.01 | Purity: 99% |
Storage: -20°C Freezer | |
  |

Catalog Number: | D25000 | CAS No.: | 302962-49-8 | |
MDL: | Formula: | C22H26ClN7O2S | ||
F.W.: | 488.01 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | White to Off-White Solid | M.P.: | >250°C (dec.) | |
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | DMSO, Methanol | Stability: | ||
Storage: | -20°C Freezer | Category: | Reference Standard | |
Reference: | Lombardo, L.J., et al: J. Med. Chem., 47, 6658 (2004), Shah, N. P., et al.: Science, 305, 399 (2004), O’Hare, T., et al.: Curr. Opin. Genet. Dev., 16, 92 (2006), | |||
Application: | A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. | |||
Category: | Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors, |